We are live on
!
Find out more
AI
Analytic Investors Portfolio holdings
AUM
$8.93B
1-Year Est. Return
13.54%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.48B
AUM Growth
+$359M
(+5%)
Cap. Flow
+$584M
Cap. Flow
% of AUM
7.8%
Top 10 Holdings %
Top 10 Hldgs %
21.43%
Holding
699
New
142
Increased
200
Reduced
165
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Non-Voting
MKC
|
+$89.6M |
| 2 |
Sysco
SYY
|
+$82.3M |
| 3 |
Cardinal Health
CAH
|
+$72M |
| 4 |
Lockheed Martin
LMT
|
+$70M |
| 5 |
AT&T
T
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$91.5M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$65.4M |
| 3 |
Entergy
ETR
|
+$54.8M |
| 4 |
IBM
IBM
|
+$48.2M |
| 5 |
Eli Lilly
LLY
|
+$36.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 30.79% |
| 2 | Healthcare | 14.4% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$634B
| $233M | 3.11% |
2,494,699
+193,782
| +8% | +$18.7M |
|
2
Clorox
CLX
$11.6B
| $191M | 2.56% |
1,656,645
-174,161
| -10% | -$19.6M |
|
3
Dollar General
DG
$25.9B
| $187M | 2.51% |
2,587,354
+370,199
| +17% | +$28.3M |
|
|
4
AT&T
T
$165B
| $167M | 2.23% |
6,789,496
+1,848,286
| +37% | +$47.1M |
|
5
Cencora
COR
$60.3B
| $145M | 1.94% |
1,527,899
+15,353
| +1% | +$1.61M |
|
6
Walmart Inc
WMT
$871B
| $142M | 1.9% |
6,588,531
+998,721
| +18% | +$22.9M |
|
7
Verizon
VZ
$194B
| $139M | 1.86% |
3,201,062
+288,991
| +10% | +$13.3M |
|
8
Southern Company
SO
$110B
| $136M | 1.82% |
3,052,125
-356,231
| -10% | -$15.6M |
|
9
Altria Group
MO
$122B
| $132M | 1.76% |
2,426,782
-542,254
| -18% | -$29.1M |
|
10
PepsiCo
PEP
$186B
| $129M | 1.72% |
1,367,863
+75,678
| +6% | +$7.2M |
|
11
Keurig Dr Pepper
KDP
$40.4B
| $128M | 1.71% |
1,616,258
+153,852
| +11% | +$12.1M |
|
12
Costco
COST
$415B
| $125M | 1.67% |
862,506
+106,008
| +14% | +$15.1M |
|
|
13
Lockheed Martin
LMT
$134B
| $123M | 1.64% |
591,952
+344,277
| +139% | +$70M |
|
14
Hershey
HSY
$35.4B
| $122M | 1.64% |
1,332,918
+472,572
| +55% | +$43.1M |
|
15
Cboe Global Markets
CBOE
$29.8B
| $120M | 1.6% |
1,790,000
+716,394
| +67% | +$45.2M |
|
16
Aramark
ARMK
$15B
| $119M | 1.6% |
5,580,504
+1,531,249
| +38% | +$35M |
|
|
17
Cardinal Health
CAH
$53.4B
| $117M | 1.57% |
1,525,583
+861,126
| +130% | +$72M |
|
18
Kimberly-Clark
KMB
$36.4B
| $109M | 1.46% |
999,993
+366,828
| +58% | +$40.4M |
|
|
19
McCormick & Company Non-Voting
MKC
$13.4B
| $101M | 1.34% |
2,448,826
+2,204,716
| +903% | +$89.6M |
|
20
Bunge Global
BG
$23.6B
| $101M | 1.34% |
1,371,190
-65,347
| -5% | -$5.06M |
|
21
Kroger
KR
$34.8B
| $98.7M | 1.32% |
2,735,857
-757,113
| -22% | -$28.1M |
|
22
Everest Group
EG
$15.2B
| $92.2M | 1.23% |
531,745
+20,753
| +4% | +$3.75M |
|
|
PNRA
23
DELISTED
Panera Bread Co
PNRA
| $90.5M | 1.21% |
468,083
+67,990
| +17% | +$12.7M |
|
|
24
Sysco
SYY
$39.7B
| $84M | 1.12% |
+2,156,702
| New | +$82.3M |
|
25
Target
TGT
$62.1B
| $81M | 1.08% |
1,029,372
+25,075
| +2% | +$2M |
|
Similar funds
JHC
SAMC
EDRAMF
PRA
TH
GF
ACN
GAIA
Analytic Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Analytic Investors held 699 positions worth $7.48B, up 5% from $7.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Analytic Investors deployed $584M of net new capital in Q3 2015, opening 142 new positions and adding to 200 existing holdings. Its largest new stake was Sysco: 2,156,702 shares worth $84M.
By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $91.5M trimmed.
- Analytic Investors's largest Q3 2015 buy was Sysco: 2,156,702 shares worth $84M.
- Analytic Investors added most to McCormick & Company Non-Voting in Q3 2015, an estimated $89.6M increase.
- Analytic Investors's biggest Q3 2015 reduction was Merck, cutting an estimated $91.5M.
- Analytic Investors fully exited OMNICARE INC in Q3 2015, selling an estimated $31.3M.
- Analytic Investors's ten largest holdings make up 21% of its $7.48B portfolio in Q3 2015.
- Analytic Investors opened 142 new positions and closed 156 in Q3 2015.
- Analytic Investors's portfolio value rose 5% quarter-over-quarter to $7.48B.
Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.